Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125829372 | 12582937 | 2 | F | 20160718 | 20160728 | 20160722 | 20160802 | PER | PHEH2016US018224 | NOVARTIS | 68.07 | YR | F | Y | 0.00000 | 20160802 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125829372 | 12582937 | 1 | PS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 1-2: 0.0625 MG (0.25 ML), QOD | 125290 | .25 | ML | SOLUTION FOR INJECTION | |||||||
125829372 | 12582937 | 2 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | WEEKS 3-4: 0.125 MG (0.5 ML), QOD | 125290 | .5 | ML | SOLUTION FOR INJECTION | |||||||
125829372 | 12582937 | 3 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 0.75 ML, (WEEKS 5 AND 6) (0.1875 MG) QOD | 125290 | .75 | ML | SOLUTION FOR INJECTION | |||||||
125829372 | 12582937 | 4 | SS | EXTAVIA | INTERFERON BETA-1B | 1 | Subcutaneous | 1 ML, (WEEKS7+) (0.25 MG)QOD | 125290 | 1 | ML | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125829372 | 12582937 | 1 | Multiple sclerosis |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125829372 | 12582937 | Chills | |
125829372 | 12582937 | Cold sweat | |
125829372 | 12582937 | Headache | |
125829372 | 12582937 | Inappropriate schedule of drug administration | |
125829372 | 12582937 | Insomnia | |
125829372 | 12582937 | Malaise | |
125829372 | 12582937 | Nausea | |
125829372 | 12582937 | Pyrexia | |
125829372 | 12582937 | Quality of life decreased | |
125829372 | 12582937 | Sleep disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125829372 | 12582937 | 1 | 20160710 | 0 | ||
125829372 | 12582937 | 2 | 20160718 | 0 |